Objective: The aim: To evaluate and analyze early and late results of treatment of patients with rectal cancer after chemotherapy.
Patients And Methods: Materials and methods: The study is based on the results of observation of 779 patients with stage II, III and IV rectal cancer (RC) who were divided into groups according to the chemotherapy treatment.
Results: Results: In the course of chemotherapy treatment of RC patients, most of them received the FOLFOX regimen treatment - 87 patients (43.